Harbor Capital Advisors Inc. Buys 38,885 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Harbor Capital Advisors Inc. grew its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 86,411.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,930 shares of the company's stock after purchasing an additional 38,885 shares during the period. Harbor Capital Advisors Inc.'s holdings in HealthEquity were worth $3,440,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Entropy Technologies LP bought a new stake in HealthEquity during the 4th quarter worth approximately $224,000. Peterson Wealth Services grew its stake in shares of HealthEquity by 5.1% in the fourth quarter. Peterson Wealth Services now owns 10,507 shares of the company's stock worth $1,008,000 after purchasing an additional 509 shares during the last quarter. Louisiana State Employees Retirement System raised its position in HealthEquity by 0.4% during the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after purchasing an additional 100 shares during the last quarter. Legato Capital Management LLC acquired a new position in HealthEquity during the 4th quarter worth about $778,000. Finally, Rhumbline Advisers grew its position in shares of HealthEquity by 0.4% in the 4th quarter. Rhumbline Advisers now owns 267,288 shares of the company's stock valued at $25,646,000 after buying an additional 1,011 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on HQY. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, June 5th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. KeyCorp reduced their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Royal Bank of Canada lifted their target price on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 4th. Finally, Bank of America boosted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $118.09.

Insider Activity at HealthEquity

In related news, Director Jon Kessler sold 134,183 shares of the company's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the sale, the director now directly owns 253,510 shares in the company, valued at approximately $28,413,400.80. This represents a 34.61% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 304,581 shares of company stock worth $33,664,018. 1.50% of the stock is owned by company insiders.

HealthEquity Stock Up 0.7%

HQY traded up $0.77 during midday trading on Friday, reaching $104.76. 854,492 shares of the company were exchanged, compared to its average volume of 836,913. The company has a market cap of $9.06 billion, a price-to-earnings ratio of 96.11, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $116.65. The company's fifty day moving average price is $93.96 and its 200 day moving average price is $97.86. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.81 by $0.16. The firm had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the business posted $0.80 EPS. As a group, analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.